Position
Chief Science Officer
Company
Cure Rare Disease
BostonBiotechnologyHealth CareTherapeuticsNon ProfitDescription
Cure Rare Disease has announced the appointment of Keith Sutton, PhD, as Chief Science Officer. Keith brings extensive scientific expertise to the organization as it works to advance therapeutic development for rare disease patients.
Quick answer
Cure Rare Disease Appoints Keith Sutton as Chief Science Officer (June 9, 2025). Cure Rare Disease is based in Boston, Massachusetts, United States.
- Who is the new Chief Science Officer at Cure Rare Disease?
- Cure Rare Disease named Keith Sutton Chief Science Officer, announced June 9, 2025.
- What did Cure Rare Disease announce on June 9, 2025?
- Cure Rare Disease has announced the appointment of Keith Sutton, PhD, as Chief Science Officer. Keith brings extensive scientific expertise to the organization as it works to advance therapeutic development for rare disease patients.
- What does Cure Rare Disease do?
- Cure Rare Disease, a 501(c)(3) nonprofit biotechnology company based in Woodbridge, CT, is transforming possibilities for people with ultra-rare diseases by developing advanced therapeutics in time to save lives.
- Where is Cure Rare Disease based?
- Cure Rare Disease is based in Boston, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Lyell Immunopharma (June 9, 2025), Beacon Therapeutics (June 9, 2025), FibroBiologics (June 9, 2025) and RxMP Therapeutics (June 9, 2025) also announced leadership changes within 45 days of Cure Rare Disease.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Non Profit
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Lyell Immunopharma Appoints David Shook as Chief Medical Officer and Mark Meltz as General Counsel (June 9, 2025)
- Beacon Therapeutics Appoints Dr. Daniel Chung as Chief Medical Officer (June 9, 2025)
- FibroBiologics Appoints Jason D. Davis as Chief Financial Officer (June 9, 2025)
- RxMP Therapeutics Appoints Shawna Khouri as Chief Operating Officer (June 9, 2025)
- Abcuro Appoints Courtney Cupples as Chief Commercial Officer (June 9, 2025)
- Vivex Biologics Appoints Jon E. Block as Chief Clinical Officer (June 10, 2025)
Who to call at Cure Rare Disease, and when
A new leader at Cure Rare Disease brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Cure Rare Disease raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cure Rare Disease, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cure Rare Disease. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cure Rare Disease changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Cure Rare Disease changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.